The angiotensin AT 1 receptor antagonist irbesartan has near-peptide affinity and potently blocks receptor signaling

By Hines J.   Fluharty S.J.   Sakai R.R.  

European Journal of Pharmacology, Vol. 384, Iss. 1, 1999-11 ,pp. : 81-89

Elsevier

Access to resources Recommend Favorite

Possible mechanism for the anemia induced by candesartan cilexetil (TCV-116), an angiotensin II receptor antagonist, in rats

By Naeshiro I.   Sato K.   Chatani F.   Sato S.  

European Journal of Pharmacology, Vol. 354, Iss. 2, 1998-08 ,pp. : 179-187

Elsevier

Access to resources Recommend Favorite

Irbesartan, an angiotensin II receptor antagonist, with selective PPAR‐gamma‐modulating activity improves function and structure of chemotherapy‐damaged ovaries in rats

By  

Fundamental & Clinical Pharmacology, Vol. 29, Iss. 3, 2015-06 ,pp. : 286-298

John Wiley & Sons Inc

Access to resources Recommend Favorite

Substituted Benzimidazole Derivatives as Angiotensin II -AT1 Receptor Antagonist: A Review

By  

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 14, 2010-12 ,pp. : 1366-1384

Bentham Science Publishers

Access to resources Recommend Favorite

Nonpeptide angiotensin II receptor antagonist recognizes inter-species differences in angiotensin AT 1 receptors

By Kawano K.-i.   Fujishima K.   Nagura J.   Yasuda S.   Shinki   Hachisu M.   Konno F.  

European Journal of Pharmacology, Vol. 357, Iss. 1, 1998-09 ,pp. : 33-39

Elsevier

Access to resources Recommend Favorite